Respiratory Syncytial Virus Infections
📧 Sign up to get email alerts when something new happens for Respiratory Syncytial Virus Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended Lower Respiratory Tract Infection Due to Respiratory Syncytial Virus in Healthy Late Preterm and Term Infants (MELODY) [Phase 3]
Phase 3 MELODY trial evaluating MEDI8897 for prevention of medically attended lower respiratory tract infections due to RSV in healthy late …
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Viral Inhibition in Children for Treatment of RSV [Phase 2]
Phase 2 trial update on viral inhibition for respiratory syncytial virus infections in children; study completed.
-
CLINICAL_TRIALS trial_result · 2024-02-13Clinical Trial Update: A Study of AK0529 in Chinese Infants Hospitalized With RSV [Phase 3]
Phase 3 trial update for AK0529 in Chinese infants hospitalized with Respiratory Syncytial Virus infections has completed.
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: A Study on the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers [Phase 3]
Phase 3 study of an unadjuvanted RSV maternal vaccine in high-risk pregnant women and infants born to vaccinated mothers was terminated; res…
-
CLINICAL_TRIALS trial_result · 2023-10-05Clinical Trial Update: A Phase III Study to Assess the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response and Safety of RSV Maternal Vaccine When Given Alone or Co-administered With GSK's Influenza D-QIV Vaccine in Healthy Non-pregnant Women. [Phase 3]
A Phase III trial evaluating lot-to-lot consistency, immune response, and safety of GSK's RSV maternal vaccine administered alone or with in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: A Study to Evaluate the Safety of MEDI8897 for the Prevention of Medically Attended Respiratory Syncytial Virus(RSV) Lower Respiratory Track Infection (LRTI) in High-risk Children [Phase 2, Phase 3]
Clinical trial update for MEDI8897 evaluating safety for prevention of medically attended RSV LRTI in high-risk children; completed phases 2…
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: A Study of Outcomes and Events of Interest in Pregnant Women, Neonates and Infants and of RSV Surveillance [NA]
A completed clinical trial studying outcomes and events of interest in pregnant women, neonates, and infants, with RSV surveillance data; re…
-
CLINICAL_TRIALS trial_result · 2023-04-14Clinical Trial Update: Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV) [Phase 2]
Phase 2 study of JNJ-53718678 in adults and adolescents with RSV infection after hematopoietic stem cell transplantation was terminated. Res…
-
CLINICAL_TRIALS trial_result · 2023-04-07Clinical Trial Update: A Study to Evaluate the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine in Healthy Non-pregnant Females From 9 to 49 Years of Age [Phase 3]
Phase 3 trial evaluating safety and immune response of an unadjuvanted RSV maternal vaccine in healthy non-pregnant females aged 9-49; study…
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: Study to Evaluate Antiviral Activity, Safety, and Pharmacokinetics of Repeated Doses of Orally Administered JNJ 53718678 Against Respiratory Syncytial Virus Infection. [Phase 2]
Phase 2 trial evaluating antiviral activity, safety, and pharmacokinetics of repeated doses of JNJ 53718678 for respiratory syncytial virus …
-
CLINICAL_TRIALS trial_result · 2022-10-18Clinical Trial Update: A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 60 Years and Above [Phase 3]
Phase 3 trial evaluating the immune response and safety of an RSV vaccine given alone and with an influenza vaccine in adults aged 60 years …
-
CLINICAL_TRIALS trial_result · 2022-07-27Clinical Trial Update: Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV [Phase 1, Phase 2]
Phase 1/2 clinical trial update for an RSV investigational vaccine in infants 6–7 months old completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-06-28Clinical Trial Update: A Study to Explore the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JNJ-53718678 at Two Dose Levels in Non-Hospitalized Adult Participants Infected With Respiratory Syncytial Virus [Phase 2]
This Phase 2 trial assessed the antiviral activity, clinical outcomes, safety, tolerability, and pharmacokinetics of JNJ-53718678 in non-hos…
-
CLINICAL_TRIALS trial_result · 2022-05-27Clinical Trial Update: RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women. [Phase 2]
Phase 2 clinical trial update for a maternal immunization RSV F vaccine in healthy third-trimester pregnant women (completed).
-
CLINICAL_TRIALS withdrawal · 2022-04-07Clinical Trial Update: A Study of Safety, Reactogenicity and Immune Response of the Repeat Vaccination Against RSV When Given to Female Participants of 18-49 Years of Age During Their Subsequent Uncomplicated Pregnancy [Phase 3]
Phase 3 clinical trial evaluating repeat RSV vaccination in pregnant women has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-12-13Clinical Trial Update: Study of Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline's (GSK)Respiratory Syncytial Virus (RSV)Maternal Unadjuvanted Vaccine in Healthy Pregnant Women (Aged 18 to 40 Years) and Their Infants [Phase 2]
Phase 2 trial assessing safety, reactogenicity, and immunogenicity of GSK's maternal unadjuvanted RSV vaccine in healthy pregnant women and …
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants [Phase 1, Phase 2]
Clinical trial update for GSK's RSV vaccine based on chimpanzee adenovector (ChAd155-RSV) in RSV-seropositive infants; Phase 1/Phase 2 compl…
-
CLINICAL_TRIALS trial_result · 2021-04-13Clinical Trial Update: A Long-term Follow-up Study to Evaluate the Impact of Lumicitabine on the Incidence of Asthma and/or Wheezing in Infants and Children With a History of Respiratory Syncytial Virus Infection [Phase 2]
A Phase 2 long-term follow-up study assessing whether lumicitabine affects the incidence of asthma and/or wheezing in infants and children a…
-
CLINICAL_TRIALS trial_result · 2021-02-15Clinical Trial Update: Respiratory Syncytial Virus - RSV Protocol [Phase 2]
Phase 2 RSV protocol trial completed; results posted in 2021 for a study sponsored by MD Anderson Cancer Center investigating respiratory sy…
-
CLINICAL_TRIALS trial_result · 2020-12-11Clinical Trial Update: A Study to Assess Safety, Tolerability and Immunogenicity of the Live Attenuated hRSV Vaccine rBCG-N-hRSV [Phase 1]
Phase 1 trial assessing safety, tolerability, and immunogenicity of the live attenuated hRSV vaccine rBCG-N-hRSV; study completed with resul…
-
CLINICAL_TRIALS trial_result · 2020-09-22Clinical Trial Update: RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults [Phase 2]
Phase II trial update for the RSV-MVA-BN vaccine in adults aged 55 and older; trial completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: Anti-RSV Study in Chinese Patients (ASCENT) [Phase 2]
Phase 2 clinical trial update for an anti-RSV study conducted in Chinese patients (ASCENT) with unknown status.
-
CLINICAL_TRIALS trial_result · 2019-10-14Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Preterm Infants. [Phase 2]
Phase 2 trial evaluating the safety and efficacy of MEDI8897 to prevent medically attended RSV lower respiratory tract infection in healthy …
-
CLINICAL_TRIALS trial_result · 2019-06-14Clinical Trial Update: Evaluating the Infectivity, Safety, and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46/NS2/N/ΔM2-2-HindIII) in RSV-Seronegative Infants 6 to 24 Months of Age [Phase 1]
Phase 1 clinical trial evaluating a recombinant live-attenuated RSV vaccine in seronegative infants to assess infectivity, safety, and immun…
-
CLINICAL_TRIALS trial_result · 2018-11-20Clinical Trial Update: A Study to Rank Different Dosages of Antigen of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A), Based on Their Immune Response and Safety, When Administered to Healthy Adult Women [Phase 2]
Phase 2 trial evaluating different doses of GSK's RSV vaccine (GSK3003891A) in healthy adult women to assess immune response and safety; stu…